In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa-Reference-Cited by-同舟云学术

In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa

Published:2019-07-04 Issue:1 Volume:19 Page:
ISSN:1471-2180
Container-title:BMC Microbiology
language:en
Short-container-title:BMC Microbiol

Author:

Young Katherine^ORCID,Painter Ronald E.,Raghoobar Susan L.,Hairston Nichelle N.,Racine Fred,Wisniewski Douglas,Balibar Carl J.,Villafania Artjohn,Zhang Rumin,Sahm Daniel F.,Blizzard Timothy,Murgolo Nicholas,Hammond Milton L.,Motyl Mary R.

Funder

Merck Sharp and Dohme

Publisher

Springer Science and Business Media LLC

Subject

Microbiology (medical),Microbiology

Link

http://link.springer.com/content/pdf/10.1186/s12866-019-1522-7.pdf

Reference91 articles.

1. Savoia D. New perspectives in the management of Pseudomonas aeruginosa infections. Future Microbiol. 2014;9:917–28.

2. Ruiz L, Dominguez MA, Ruiz N, Vinas M. Relationship between clinical and environmental isolates of Pseudomonas aeruginosa in a hospital setting. Arch Med Res. 2004;35:251–7.

3. Hauser AR, Jain M, Bar-Meir M, McColley SA. Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin Microbiol Rev. 2011;24:29–70.

4. Burton DC, Edwards JR, Srinivasan A, Fridkin SK, Gould CV. Trends in catheter-associated urinary tract infections in adult intensive care units-United States, 1990-2007. Infect Control Hosp Epidemiol. 2011;32:748–56.

5. Bagshaw SM, Laupland KB. Epidemiology of intensive care unit-acquired urinary tract infections. Curr Opin Infect Dis. 2006;19:67–71.

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efflux pump-mediated resistance to new beta lactam antibiotics in multidrug-resistant gram-negative bacteria;Communications Medicine;2024-08-29

2. Resistance to ceftazidime–avibactam and other new β-lactams in Pseudomonas aeruginosa clinical isolates: a multi-center surveillance study;Microbiology Spectrum;2024-08-06

3. Not all carbapenem-resistant Pseudomonas aeruginosa strains are alike: tailoring antibiotic therapy based on resistance mechanisms;Current Opinion in Infectious Diseases;2024-07-25

4. Evolving resistance landscape in gram‐negative pathogens: An update on β‐lactam and β‐lactam‐inhibitor treatment combinations for carbapenem‐resistant organisms;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-07

5. ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics;Nature Reviews Microbiology;2024-06-03